Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Dar Zavain received 4,902 Recursion Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Apr 1, 2026 · Filed Apr 2, 2026

On Apr 1, 2026, Dar Zavain (Director) received 4,902 Recursion Pharmaceuticals, Inc. shares as an award, leaving 147,231 shares. Filed Apr 2, 2026 (Form 4).

Awarded
4,902 shares
Holding after
147,231 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Class A Common StockAward4,902147,231Direct

Source

View original at SEC

Related